ECSP11011340A - Nuevos derivados de benzotiadiazepinas, su procedimiento de preparación y composiciones farmacéuticas que los contienen - Google Patents

Nuevos derivados de benzotiadiazepinas, su procedimiento de preparación y composiciones farmacéuticas que los contienen

Info

Publication number
ECSP11011340A
ECSP11011340A EC2011011340A ECSP11011340A ECSP11011340A EC SP11011340 A ECSP11011340 A EC SP11011340A EC 2011011340 A EC2011011340 A EC 2011011340A EC SP11011340 A ECSP11011340 A EC SP11011340A EC SP11011340 A ECSP11011340 A EC SP11011340A
Authority
EC
Ecuador
Prior art keywords
benzotiadiazepinas
pharmaceutical compositions
compositions containing
preparation procedure
new derivatives
Prior art date
Application number
EC2011011340A
Other languages
English (en)
Inventor
Patrice Desos
Alexis Cordi
Pierre Lestage
Laurence Danober
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of ECSP11011340A publication Critical patent/ECSP11011340A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/36—Seven-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Abstract

NUEVOS DERIVADOS DE BENZOTIADIAZEPINAS, SU PROCEDIMIENTO DE PREPARACIÓN Y COMPOSICIONES FARMACÉUTICAS QUE LOS CONTIENEN
EC2011011340A 2009-03-20 2011-09-19 Nuevos derivados de benzotiadiazepinas, su procedimiento de preparación y composiciones farmacéuticas que los contienen ECSP11011340A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0901300A FR2943342B1 (fr) 2009-03-20 2009-03-20 Nouveaux derives de benzothiadiazepines,leur procede de preparation et les compositions pharmaceutiques qui les contiennent.

Publications (1)

Publication Number Publication Date
ECSP11011340A true ECSP11011340A (es) 2011-10-31

Family

ID=40863576

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2011011340A ECSP11011340A (es) 2009-03-20 2011-09-19 Nuevos derivados de benzotiadiazepinas, su procedimiento de preparación y composiciones farmacéuticas que los contienen

Country Status (45)

Country Link
US (1) US8236790B2 (es)
EP (1) EP2246339B1 (es)
JP (1) JP5437473B2 (es)
KR (1) KR101431504B1 (es)
CN (1) CN102361860B (es)
AP (1) AP3050A (es)
AR (1) AR075892A1 (es)
AT (1) ATE513822T1 (es)
AU (1) AU2010200815B2 (es)
BR (1) BRPI1009200A2 (es)
CA (1) CA2696705C (es)
CL (1) CL2011002287A1 (es)
CO (1) CO6361956A2 (es)
CR (1) CR20110484A (es)
CU (1) CU24030B1 (es)
CY (1) CY1111807T1 (es)
DK (1) DK2246339T3 (es)
EA (1) EA020259B1 (es)
EC (1) ECSP11011340A (es)
ES (1) ES2368691T3 (es)
FR (1) FR2943342B1 (es)
GE (1) GEP20135862B (es)
HK (1) HK1167404A1 (es)
HN (1) HN2011002458A (es)
HR (1) HRP20110626T1 (es)
IL (1) IL215016A (es)
JO (1) JO2780B1 (es)
MA (1) MA33131B1 (es)
MX (1) MX2011009638A (es)
MY (1) MY154001A (es)
NI (1) NI201100169A (es)
NZ (1) NZ595082A (es)
PE (1) PE20120113A1 (es)
PL (1) PL2246339T3 (es)
PT (1) PT2246339E (es)
RS (1) RS51919B (es)
SA (1) SA110310217B1 (es)
SG (1) SG174274A1 (es)
SI (1) SI2246339T1 (es)
TN (1) TN2011000469A1 (es)
TW (1) TWI388326B (es)
UA (1) UA100477C2 (es)
UY (1) UY32475A (es)
WO (1) WO2010106249A1 (es)
ZA (1) ZA201001905B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2464645T1 (sl) * 2009-07-27 2017-10-30 Gilead Sciences, Inc. Zlite heterociklične spojine kot ionsko kanalni modulatorji
US8703759B2 (en) 2010-07-02 2014-04-22 Gilead Sciences, Inc. Fused heterocyclic compounds as ion channel modulators
LT2603513T (lt) 2010-08-10 2020-05-25 Takeda Pharmaceutical Company Limited Heterociklinis junginys ir jo panaudojimas kaip ampa receptoriaus teigiamo alosterinio moduliatoriaus
PT2707361T (pt) 2011-05-10 2017-11-28 Gilead Sciences Inc Compostos heterocíclicos fusionados como moduladores do canal de sódio
TW201837023A (zh) * 2011-07-01 2018-10-16 美商基利科學股份有限公司 作為離子通道調節劑之稠合雜環化合物
NO3175985T3 (es) 2011-07-01 2018-04-28
AU2015224425B2 (en) * 2011-07-01 2017-02-09 Gilead Sciences, Inc. Fused benzoxazepinones as ion channel modulators
JP6134654B2 (ja) 2012-02-08 2017-05-24 武田薬品工業株式会社 複素環化合物およびその用途
CN111620838A (zh) * 2020-05-16 2020-09-04 西安都创医药科技有限公司 一种氯代苯并硫氮杂卓化合物的制备方法及其制备的产品及其应用
CN111518055A (zh) * 2020-05-16 2020-08-11 西安都创医药科技有限公司 一种苯并硫氮杂卓氧化物的制备方法及其制备的产品及其应用
CN111548325A (zh) * 2020-05-16 2020-08-18 西安都创医药科技有限公司 一种卤代苯并硫氮杂卓化合物的制备方法及其制备的产品及其应用
CN111574475B (zh) * 2020-06-03 2022-09-20 西安都创医药科技有限公司 卤代苯并硫杂卓氧化物的制备方法及其制备的产品及其应用
CN115368363B (zh) * 2021-05-17 2024-02-20 中山大学 一种手性或消旋的嘧啶并二氮杂环庚酮类化合物及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT70955A (en) * 1992-04-15 1995-11-28 Rhone Poulenc Rorer Sa 3,4-dihydro-1,1-dioxo-2h-1,2,4-benzothiadiazine-3-carboxylic acid derivatives, preparation thereof and drugs containing same
US6455522B1 (en) * 1998-02-11 2002-09-24 Bristol-Myers Squibb Pharma Company Cyclic sulfonamide derivatives as metalloproteinase inhibitors
WO1999042456A2 (en) * 1998-02-18 1999-08-26 Neurosearch A/S Novel compounds and their use as positive ampa receptor modulators
US6156746A (en) * 1998-08-25 2000-12-05 Bristol-Myers Squibb Company 1,2,5-benzothiadiazepine-1,1-dioxides with n-2 imidazolylalkyl substituents
GB0209467D0 (en) * 2002-04-25 2002-06-05 Astrazeneca Ab Chemical compounds
DE10300973A1 (de) * 2003-01-14 2004-07-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Carbonsäuren und deren Ester, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
FR2877338B1 (fr) * 2004-11-03 2007-01-26 Servier Lab Nouveaux derives de benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2879201B1 (fr) * 2004-12-10 2007-02-16 Servier Lab Nouveaux derives de benzothiazine et benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
IL215016A0 (en) 2011-11-30
CA2696705A1 (fr) 2010-09-20
CR20110484A (es) 2011-10-24
CN102361860A (zh) 2012-02-22
PT2246339E (pt) 2011-08-01
ES2368691T3 (es) 2011-11-21
EA020259B1 (ru) 2014-09-30
UY32475A (es) 2010-09-30
UA100477C2 (uk) 2012-12-25
SG174274A1 (en) 2011-10-28
CY1111807T1 (el) 2015-10-07
AU2010200815A1 (en) 2010-10-07
MA33131B1 (fr) 2012-03-01
BRPI1009200A2 (pt) 2017-06-13
KR101431504B1 (ko) 2014-08-20
GEP20135862B (en) 2013-06-25
NI201100169A (es) 2012-01-11
TN2011000469A1 (fr) 2013-03-27
MY154001A (en) 2015-04-30
ZA201001905B (en) 2010-11-24
CO6361956A2 (es) 2012-01-20
EP2246339B1 (fr) 2011-06-22
AP2011005935A0 (en) 2011-10-31
EP2246339A1 (fr) 2010-11-03
ATE513822T1 (de) 2011-07-15
CN102361860B (zh) 2014-09-10
JO2780B1 (en) 2014-03-15
SI2246339T1 (sl) 2011-09-30
TW201036615A (en) 2010-10-16
US8236790B2 (en) 2012-08-07
NZ595082A (en) 2013-12-20
FR2943342A1 (fr) 2010-09-24
PE20120113A1 (es) 2012-02-24
AU2010200815B2 (en) 2015-05-07
DK2246339T3 (da) 2011-10-10
AR075892A1 (es) 2011-05-04
CU20110169A7 (es) 2012-02-15
WO2010106249A1 (fr) 2010-09-23
HN2011002458A (es) 2014-05-19
FR2943342B1 (fr) 2011-03-04
HK1167404A1 (en) 2012-11-30
MX2011009638A (es) 2011-09-28
US20100240635A1 (en) 2010-09-23
JP2012520858A (ja) 2012-09-10
CA2696705C (fr) 2013-02-12
JP5437473B2 (ja) 2014-03-12
TWI388326B (zh) 2013-03-11
KR20110128209A (ko) 2011-11-28
CU24030B1 (es) 2014-10-02
HRP20110626T1 (hr) 2011-10-31
SA110310217B1 (ar) 2013-06-15
AP3050A (en) 2014-11-30
IL215016A (en) 2013-08-29
RS51919B (en) 2012-02-29
PL2246339T3 (pl) 2011-11-30
EA201101334A1 (ru) 2012-04-30
CL2011002287A1 (es) 2012-02-03

Similar Documents

Publication Publication Date Title
ECSP11011340A (es) Nuevos derivados de benzotiadiazepinas, su procedimiento de preparación y composiciones farmacéuticas que los contienen
GT201000023A (es) Nuevos derivados de 6-trialzolopiridacina-sulfanil benzotiazol y bencimidazol, su procedimiento de preparacion, su aplicacion como medicamentos, composiciones farmaceuticas y nueva utilizacion principalmente como inhibidores de met.
GT201200207A (es) Derivados de imidazopiridina como inhibidores de jak
CR10665A (es) Nuevos derivados de diosmetina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
GT201200321A (es) Derivados de heteroaril imidazolona como inhibidores de jak
CR20140106A (es) Compuestos y composiciones como inhibidores de la quinasa c-kit
SV2014004770A (es) Nuevos derivados de pirrol, su procedimiento de preparación y los composiciones farmacéuticas que los contienen
CR11623A (es) Compuestos
GT201200243A (es) Derivados de pirazol como inhibidores de jak
CR20130001A (es) Derivados de indolizina, su procedimiento de preparación y su aplicación en terapéutica
CO6321282A2 (es) Derivados de piperidinilindol como inhibidores de aldosterona sintasa
BR112012019529A2 (pt) inibidores de d-nitrosoglutationa redutase
HN2008001393A (es) Derivados de 1,2,4,5- tetrahidro -3h- benzazepinas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen
CL2011002258A1 (es) Compuestos derivados heterociclicos fusionados; composicion farmaceutica que los comprende; y uso de los compuestos para tratar vih.
DOP2014000098A (es) 2-tiopirimidinonas
HN2010001537A (es) Nuevos derivados dihidroindolonas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
SV2009003429A (es) Derivados de 7-alquinil-1,8-naftiridonas, su preparacion y su aplicacion en terapeutica
UY34314A (es) Derivados de anilina, su preparación y su aplicación terapéutica.
UY34166A (es) Composición farmacéutica oftalmológica tópica que contiene regorafenib
SV2010003579A (es) Derivados de pirazol como inhibidores de 5-lo
CR20120134A (es) Derivados de pirazol que modulan la estearoil-coa-desaturasa
UY33128A (es) Derivados de piridinona y composiciones farmacéuticas de los mismos
CO6771413A2 (es) Derivados de difenilamina: usos, procedimiento de síntesis y composiciones framacéuticas
CL2012001759A1 (es) Compuestos derivados de 8-hidroxiquinolina-7-carboxamida; composicion farmaceutica.
ECSP10010292A (es) Nuevos derivados de ácido 2-mercaptociclopentanocarboxílico, su procedimiento de preparación y las composiciones farmacéuticas que los contienen